A study of novel antiallergic agents with eosinophilic infiltration inhibiting action

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 1, 1999, Pages 19-24

  Kawasaki, Nobuhide ^a   Miyataka, Hideki ^a   Matsumoto, Hitoshi ^a   Yamashita, Naomi ^b   Tsuyoshi, Sakane ^b   Mizushima, Yutaka ^b   Satoh, Toshio ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [4 (DIPHENYLMETHYL) 1 PIPERAZINYL]BUTOXY] 2,3,6 TRIMETHYLPHENOL; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; HISTAMINE; HISTAMINE RELEASE INHIBITOR; HYDROQUINONE DERIVATIVE; LIPOXYGENASE INHIBITOR; MEPYRAMINE; OVALBUMIN; OXATOMIDE; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHILIA; GUINEA PIG; HISTAMINE RELEASE; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MICROSOME; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEUM EXUDATE; PERITONEUM MAST CELL; RAT; SEMINAL VESICLE; SHEEP;

ALBUMINS; ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; DRUG EVALUATION, PRECLINICAL; EOSINOPHILS; GUINEA PIGS; HISTAMINE H1 ANTAGONISTS; ILEUM; LUNG; MICE; PHENOLS; PIPERAZINES; PYRILAMINE; RATS; RESPIRATION; RESPIRATORY SYSTEM;

ANIMALIA; CAVIA; CAVIA PORCELLUS; OVIS ARIES; SUS SCROFA;

EID: 0032945025     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00676-3     Document Type: Article

References (14)

1. Present address: Department of Medicine, Teikyo University School of Medicine, Itabashi, Tokyo 173-8605, Japan.
2. Kay, A. B. J. Allergy Clin. Immunol. 1991, 87, 893.
3. a) Frew, A. J.; Kay, A. B. J. Allergy Clin. Immunol. 1990, 85, 533.
4. b) Diaz, P.; Gonzalez, M. C.; Galleguillos, F. R.; Ancic, P.; Cromwell, O.; Shepherd, D.; Durham, S. R.; Gleich, G. J.; Kay, A. B. Am. Rev. Respir. Dis. 1989, 139, 1383.
5. a) Kay, A. B. Am. Rev. Respir. Dis. 1992, 145, S22.
6. b) Hamid, Q.; Azzawi, M.; Ying, S.; Moqbel, R.; Wardlaw, A. J.; Corrigan, C. J.; Bradley, B.; Durham, S. R.; Collins, J. V.; Jeffery, P. K.; Quint, D. J.; Kay, A. B. J. Clin. Invest. 1991, 87, 1541.
7. Dahlen, S. E.; Hedqvist, P.; Hammarstrom, S.; Samuelsson, B. Nature 1980, 288, 484.
8. Palmblad, J.; Malmsten, C. L.; Uden, A. M.; Radmark, O.; Engstedt, L.; Samuelsson, B. Blood 1981, 58, 658.
9. a) Miyachi, Y. Pharma Medica 1991, 11, 193.
10. b) Yoshikuni, H. Jpn. J. Clin. Immun. 1991, 14, 166.
11. Kawasaki, N.; Miyataka, H.; Nishiki, M.; Matsumoto, H.; Inagaki, N.; Nagai, H.; Satoh, T. Chem. Pharm. Bull. 1998, submitted.
12. Takayanagi, I. Pharmacometrics 1968, 2, 131.
13. Ohmori, K.; Ishii, H.; Nito, M.; Shuto, K.; Nakamizo, N. Folia Pharmacol. Japon 1983, 81, 399.
14. Holtzman, M. J.; Aizawa, H.; Nadel, J. A.; Goetzl, E. J. Biochem. Biophys. Res. Commun. 1983, 114, 1071.